share_log

InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'

InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'

inmed pharmaceuticals股价上涨,因该公司宣布获得了美国专利US 12083229 B2 16/611837,用于“眼部药物给药配方”。
Benzinga ·  09/10 16:21

InMed Pharmaceuticals Shares Are Trading Higher After the Company Announced It Was Granted U.S. Patent US 12083229 B2 16/611837 for 'Ocular Drug Delivery Formulation'

inmed pharmaceuticals股价上涨,因该公司宣布获得了美国专利US 12083229 B2 16/611837,用于“眼部药物给药配方”。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发